Thurston, Springer, Miller, Herd & Titak, Inc. Jazz Pharmaceuticals PLC Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $330 Million
- Q3 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 65 shares of JAZZ stock, worth $7,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65
Previous 64
1.56%
Holding current value
$7,740
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
501Shares Held
57.8MCall Options Held
155KPut Options Held
152K-
Vanguard Group Inc Valley Forge, PA6.32MShares$753 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.15MShares$732 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL2.48MShares$295 Million0.58% of portfolio
-
Capital World Investors Los Angeles, CA2.02MShares$240 Million0.04% of portfolio
-
State Street Corp Boston, MA2.02MShares$240 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.46B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...